Loading clinical trials...

Long-term Survival of THA After Pelvic and/or Femoral Osteotomy | Clinical Trials | Clareo Health

NOT_YET_RECRUITING

Long-term Survival of THA After Pelvic and/or Femoral Osteotomy

NCT06959498•Central Hospital, Nancy, France

Summary

Analyze the long-term clinical and radiological outcomes of total hip arthroplasty (THA) in patients with hip dysplasia treated by pelvic osteotomy, femoral osteotomy, shelf acetabuloplasty, or a combination of these interventions, performed during childhood or early adulthood. The aim is to understand the impact of these early interventions on THA survival and long-term joint function.

Eligibility

Age

All ages

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•patients who underwent THA between 1998 and 2010 and had a prior surgical treatment for hip dysplasia (pelvic, femoral osteotomy, shelf acetabuloplasty or combined osteotomy)

Exclusion Criteria

•\-

Key Dates

Start Date

May 1, 2025

Primary Completion Date

May 15, 2025

Completion Date

June 1, 2025

Last Updated

May 6, 2025

Enrollment

ESTIMATED participants

Conditions

Hip Arthropathy Associated With Other ConditionsHip DysplasiaSurvival, Prosthesis

Interventions

Total hip arthroplasty

PROCEDURE

Contacts

Julia Richard

CONTACT

+33628749343 julia.richard97@gmail.com

Oliver Roche

CONTACT

o.roche@chru-nancy.fr

Pain Injection Versus Epidural Anesthesia for Hip Surgery in Pediatric Patients With Cerebral Palsy

NCT06189781

Cerebral PalsyHip Dysplasia+1 more

View study

ACTIVE_NOT_RECRUITING

PMCF Study on the Safety and Performance of the Zimmer® Maxera™ Acetabular System in Total Hip Arthroplasty

NCT03372278

Rheumatoid Arthritis With Adequate Bone QualityInflammatory Arthritis+4 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 6, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Long-term Survival of THA After Pelvic and/or Femoral Osteotomy

Inclusion Criteria

Exclusion Criteria

Pain Injection Versus Epidural Anesthesia for Hip Surgery in Pediatric Patients With Cerebral Palsy

PMCF Study on the Safety and Performance of the Zimmer® Maxera™ Acetabular System in Total Hip Arthroplasty

The Medacta International AMIStem-P Post-Marketing Surveillance Study

Mixed-Methods Evaluation of Short-, Medium-, and Long-Term Outcomes Following Hip Treatment

AMIStem Primary Hip System Prospective Post-marketing Multi-centre Surveillance Study

Actis Total Hip System 2 Year Follow-up